Joel Barrish, Ph.D., has been appointed chief scientific officer and executive vice president, Achillion Pharmaceuticals. Dr. Barrish has more than 30 years of experience in the pharmaceutical industry. Most recently, he was vice president and head of Discovery Chemistry at Bristol-Myers Squibb, leading chemical research on small molecules and other modalities across all therapeutic areas and sites. Prior to that, he was responsible for teams at BMS that advanced more than 20 compounds into clin...